Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)
Clinical trial NCT01532726 · COMPLETED
Trial details
- NCT number
- NCT01532726
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-03-01
- Primary completion
- 2014-09-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.